Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Movano Inc MOVE

Technology Scientific & Technical Instruments


NDAQ:MOVE - Post by User

Movano Inc
<< Previous
 Bullboard Posts
User Avatar Image
(302)
•••
  • whytestocksX
Post by whytestockson Nov 04, 2024 7:15pm
44 Views
Post# 36296241

Movano Health Submits Response to FDA as Part of Final Revie

Movano Health Submits Response to FDA as Part of Final Revie
News; $MOVE Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMEDMovano Health Submits Response to FDA as Part of Final Review Phase for EvieMED PR Newswire Company remains optimistic on the potential for this pioneering healthcare solution PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ...MOVE - Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities